Patent details
EP3143047
Title:
BELIMUMAB FORMULATION
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP3143047
WO Application Number:
IB2015053602
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15724070.6
WO Publication Number:
WO2015173782
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:
Dates
Filing date:
15/05/2015
Grant date:
20/07/2022
EP Publication Date:
22/03/2017
WO Publication Date:
19/11/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
13/10/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/07/2022
EP B1 Publication Date:
20/07/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/05/2035
Lapsed By Expiration Date:
Patent Validated Date:
03/11/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
19/02/2026
Name:
GlaxoSmithKline Intellectual Property Management Limited
Address:
GSK Medicines Research Centre,
Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)
From:
19/02/2026
Name:
GlaxoSmithKline Intellectual Property Limited
Address:
GSK Medicines Research Centre,
Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)
Historical Applicant/holder
From:
21/04/2023
To:
19/02/2026
Name:
GlaxoSmithKline Intellectual Property Limited
Address:
980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
From:
20/07/2022
To:
19/02/2026
Name:
GlaxoSmithKline Intellectual Property Management Limited
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)
From:
20/07/2022
To:
21/04/2023
Name:
GlaxoSmithKline Intellectual Property Limited
Address:
980 Great West Road, TW8 9GS, Brentford, Misslesex, United Kingdom (GB)
Inventor
1
Name:
BLAKE-HASKINS, Angela
Address:
Gaithersburg, Maryland 20878, United States of America (US)
2
Name:
MARSHALL, Tristan
Address:
Rockville, Maryland 20850, United States of America (US)
3
Name:
O'BERRY, Kristen
Address:
Gaithersburg, Maryland 20878, United States of America (US)
4
Name:
PERKINS, Melissa D.
Address:
McPherson, Kansas 67460, United States of America (US)
Priority
1
Priority Patent Number:
201462095181 P
Priority Date:
22/12/2014
Priority Country:
United States of America (US)
2
Priority Patent Number:
201462093734 P
Priority Date:
18/12/2014
Priority Country:
United States of America (US)
3
Priority Patent Number:
201461994427 P
Priority Date:
16/05/2014
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
C07K 16/28 ;
A61K 39/395 ;
Publication
Bulletin
1
Bulletin Heading:
EP3
Journal edition number:
45/22
Publication date:
09/11/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
2
Bulletin Heading:
EP2
Journal edition number:
29/22
Publication date:
20/07/2022
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202236
Publication date:
07/09/2022
Description:
Document reprinted after correction (B8, B9)
2
Issue number:
202229
Publication date:
20/07/2022
Description:
Grant (B1)
Deed
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202600240A
Date Registered:
19/02/2026
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Anaqua Services
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202300837A
Date Registered:
21/04/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
E. Van Malderen
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
12
Annual Fee Amount:
600 Euro
Last Annual Payment Date:
23/04/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
500 Euro
Payer:
Anaqua Services
Filing date
Document type
Document Description
Number of pages
File Type
02/11/2022
Outgoing Correspondence
Letter no formal defects
1
PDF
/4/7/4/7/0/0800807474/docs/ep15724070.6_1_512684l271.pdf
13/10/2022
Claims
First filed claims
3
PDF
/4/7/4/7/0/0800807474/docs/ep15724070.6_0_claims20221013114727673.pdf